Cover Image
市場調查報告書

全球膽固醇檢驗市場

Cholesterol Testing

出版商 Global Industry Analysts, Inc. 商品編碼 236841
出版日期 內容資訊 英文 220 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球膽固醇檢驗市場 Cholesterol Testing
出版日期: 2014年09月01日 內容資訊: 英文 220 Pages
簡介

本報告提供全球膽固醇檢驗市場相關調查,為您彙整美國,加拿大,日本,歐洲,亞太地區,中東,南美等地區別分析,今後的市場預測,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 膽固醇檢驗:概要
    • 現在及未來分析
    • 醫療費擴大促進檢驗市場
    • 已開發國家的莫大可能性
  • 趨勢,促進要素,課題
    • 心血管疾病的全球性擴大:主要的成長因素
    • 預防醫學趨勢擴大成長
    • 技術進步改善了膽固醇檢驗
    • 智慧型手機的膽固醇檢驗
    • 智慧型手機的銷售額擴大:商務案例
    • 非侵入式膽固醇檢驗擴大需求 其他
  • 心血管疾病概要
    • 心臟病概要
    • 心血管疾病的種類
    • 高血壓
    • 冠狀動脈疾病
    • 為配合心血管疾病的2個方法
  • 膽固醇的易處與壞處
  • 膽固醇檢驗與心血管風險評估技術
    • 膽固醇檢驗的必要性
    • 膽固醇檢驗的候選人
    • 檢驗次序
    • 檢驗時間
    • 膽固醇檢驗的種類
  • 定點照護及居家膽固醇檢驗
  • 膽固醇控制和治療方法
  • 產品引進/技術創新
  • 近幾年的產業活動
  • 主要企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
  • 南美
  • 其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-3403

This report analyzes the worldwide markets for Cholesterol Testing in Million Units by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 32 companies including many key and niche players such as -

Abbott Diagnostics, Inc.
AccuTech, LLC
Alere Inc.
Beckman Coulter, Inc.
Chek Diagnostics

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • A. Lipid Panel Test/Complete Lipid Profile
      • Total Cholesterol Test
      • HDL Cholesterol Test
      • LDL Cholesterol Testing
      • Triglycerides/VLDL Cholesterol Testing
    • B. Apolipoprotein B
    • C. Other Apolipoprotein Tests

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Cholesterol Testing - An Overview
  • Current & Future Analysis
  • Increasing Healthcare Expenditure to Promote Testing Market
    • Table 1: Per-Capita Healthcare Expenditure in US$ for Select Regions (2013) (includes corresponding Graph/Chart)
  • Developing Economies Offer Significant Potential
    • Table 2: Healthcare Spending as Percentage of GDP in Select Developing Countries (2012) (includes corresponding Graph/Chart)
    • Table 3: Healthcare Spending as Percentage of GDP in Select Developed Countries for 2004, 2008 & 2012 (includes corresponding Graph/Chart)

2. TRENDS, DRIVERS & CHALLENGES

  • Global Menace of Cardiovascular Disease - Major Growth Factor
    • Table 4: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
    • Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 8: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
  • Preventive Healthcare Trend to Expand Growth
  • Technological Advances to Improve Cholesterol Testing
  • Cholesterol Testing With Smartphone
  • Growing Smartphone Sales - A Business Case
    • Table 9: Top Ten Countries by Mobile Subscriptions in Millions (2012) (includes corresponding Graph/Chart)
    • Table 10: World Smartphone Market: Sales in Million Units by Geographic Region/Country for 2013 & 2017 (includes corresponding Graph/Chart)
  • Non-Invasive Cholesterol Tests to Drive Demand
  • Digital Photographs to Screen Cholesterol
  • Miniature Sensors - The Future of Cholesterol Testing
  • Natriuretic Peptides (BNP and NT-proBNP) - New Cardiac Markers
  • The Rise of C-reactive Protein Tests
  • Global In-Vitro Diagnostics Market Signals Prospects
    • Table 11: Global In-Vitro Diagnostics Market by Test Category (2013): Percentage Breakdown of Value Sales for Anatomic Pathology, Blood Screen Immunoassay, Coagulation, Hematology, Immunoassay, Microbiology, Molecular Diagnostics, Point-of-Care Diagnostics, and Others (includes corresponding Graph/Chart)
    • Table 12: Global In-Vitro Diagnostics Market by Sector (2013): Percentage Breakdown of Revenues for Decentralized & Patient Self-Testing, and Hospital & Commercial Laboratories (includes corresponding Graph/Chart)
    • Table 13: Global Market for In-Vitro Diagnostics by Geographic Region (2013): Percentage Share Breakdown of Value Sales for Asia-Pacific (Excl. Japan), EMEA, Japan, Latin America and North America (includes corresponding Graph/Chart)
  • Cardiac IVD Market Offers Potential
  • POC Testing: Potential Opportunities Ahead
  • Complexities in the POC Diagnostics Market
  • Aging Population - A Vital Demography for Cholesterol Testing
    • Table 14: Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/Regions (2013) (includes corresponding Graph/Chart)
    • Table 15: Global Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Risk of CVD in Obesity Offers Prospects for Cholesterol Testing
    • Table 16: Global Obese Population in Millions by Region/Country (2013) (includes corresponding Graph/Chart)
    • Table 17: Global Obesity Levels (2013): Percentage Share Breakdown of Total Obese Population by Leading Countries (includes corresponding Graph/Chart)
  • Diabetics at Higher Risk of Heart Diseases
    • Table 18: Worldwide Prevalence of Diabetes Mellitus by Geographic Region (2013 & 2035P) (includes corresponding Graph/Chart)
  • The Hypertension-Cholesterol Link to Drive Demand
    • Table 19: Death Rates Due to Hypertension in Select Countries: 2011
    • Table 20: Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 & 2010) (includes corresponding Graph/Chart)
  • E-Retailing Drives Demand for Home Test Kits
    • Table 21: Factors Influencing Online Purchase Decision - Percentage Share Breakdown of Consumer Preferences by Criteria (includes corresponding Graph/Chart)

3. AN INSIGHT INTO CARDIOVASCULAR DISEASES

  • The Heart of Heart Problems
  • Types of Cardiovascular Diseases/Disorders
  • Coronary Artery Disease
  • Hyperlipidemia - An Important Risk Factor of Heart Disease
    • Hypertension - The Silent Killer
  • Two-Pronged Approach to Counter CVD
    • Cardiovascular Risk Assessment
    • Reality Check

4. GOOD & BAD OF CHOLESTEROL

  • Blood Cholesterol - The Principal Cardiac Risk Marker
  • Types of Cholesterol
  • Total Cholesterol (TC)
  • High Density Lipoprotein (HDL)
  • Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL)
  • Triglycerides (TRG)
  • Glucose (GLU)
  • Alanine Aminotransferase (ALT)
  • Outcomes of High Blood Cholesterol
  • Atherosclerosis
  • Coronary Heart Disease (CHD)
  • Risk Factors and Risk Levels
  • Risk Factors
  • Risk Levels
  • Risk Level Based on Total Cholesterol Concentration
    • LDL-Cholesterol Risk Levels
    • HDL-Cholesterol Risk Levels
    • Triglyceride Risk Levels

5. CHOLESTEROL TESTING & CVD RISK ASSESSMENT TECHNIQUES

  • Need for Cholesterol Testing
  • Candidates for Cholesterol Testing
  • Test Procedure
  • Time of Testing - Crucial for Heart Disease Patients
  • Types of Cholesterol Testing
    • Lipid Panel Test/Lipid Profile
      • Total Cholesterol Test
      • HDL Cholesterol Test
      • LDL Cholesterol Testing
      • LDL Cholesterol Test - The First Cholesterol Testing Method
      • Triglycerides/VLDL Cholesterol Testing
    • Apolipoprotein B Test
    • Other Cholesterol Tests
      • Apolipoprotein A-1 Test
      • ApoE Genotyping Test
      • Apolipoprotein CII
    • Other Key Markers for Cholesterol Testing
      • RLP Cholesterol
      • Non Instrumented Technologies
    • Heart Disease Diagnosis Tests
      • Non-Invasive Tests
      • Invasive Tests
      • Other CVD Markers
      • Creatine Kinase MB
      • Troponin T and Troponin I
      • Myoglobin
      • P-selectin Profile
      • C-reactive Protein
      • Endothelial Dysfunction
      • Homocysteine
      • Plasminogen Activator Inhibitor-1
      • s-100 Protein
      • Thrombus Precursor Protein
      • Other Cardiac Markers

6. POINT OF CARE & HOME CHOLESTEROL TESTING

  • Point of Care (POC) Medical Diagnostics
    • Table 22: Global Point of Care Diagnostics Market by Segment (2013): Percentage Breakdown of Revenues for Commercial Labs, Hospital Labs, Point of Care and Self Testing (includes corresponding Graph/Chart)
  • POC Testing Market
    • Table 23: Global Point-of-Care Diagnostics Market by POC Tests (2013 & 2015): Percentage Share Breakdown of Revenues for Blood Chemistry, Cardiac Markers, Cholesterol, Drug & Alcohol, Glucose Monitoring, Hemoglobin, Tumor Markers, and Others (includes corresponding Graph/Chart)
  • Development of Home Cholesterol Testing Kits
  • Cholesterol and Other Cardiovascular Test Kits Offered by Select Companies

7. CHOLESTEROL CONTROL & TREATMENT MODALITIES

  • Prevention is better than Cure
  • Dietary Therapy
    • Healthy Diet
    • Exercises
  • Drug Therapy
    • Classification of Cholesterol Lowering Drugs
      • Bile Acid Sequestrants
      • Nicotinic Acid
      • HMG CoA Reductase Inhibitors (Statins)
      • Other Drugs (Fibric Acids and Probucol)
      • Testing After Commencing Drug Therapy

8. PRODUCT INTRODUCTIONS/INNOVATIONS

  • CODIX Introduces SelexOn™
  • Health Canada Approves Abbott's ARCHITECT STAT High Sensitive Troponin-I Assay
  • PTS Unveils CardioChek® Plus
  • ACON Introduces Mission® Systems
  • Everist Genomics to Unveil AngioDefender
  • Pathway Genomics Introduces InsightSM
  • Boston Heart Diagnostics Unveils SLCO1B1 Genotype Test
  • diaDexus Unveils PLAC® Test in Europe

9. RECENT INDUSTRY ACTIVITY

  • PTS Switches Name to Chek Diagnostics
  • LipoScience Parts Ways with Health Diagnostics
  • Miraculins and Citizen Doctor Sign Distribution Deal
  • Akers Biosciences Signs Distribution Deal for Rapid Tests in Australia, Singapore & Middle East
  • ITC Nexus Acquires Accumetrics
  • MedTest Signs Deal to Take Over Pointe Scientific
  • Response Biomedical Signs Deal for Sales Representation with Med Tech/Med Care
  • Corgenix Partners Health Diagnostic Laboratory
  • LipoScience Commences Clinical Development of NMR Diagnostics
  • Harbert Takes Over Cardioscan
  • BG Medicine Signs Deal with Kindstar Diagnostics to Offer Galectin-3 Testing Services

10. FOCUS ON SELECT PLAYERS

  • Abbott Diagnostics, Inc. (US)
  • AccuTech, LLC (US)
  • Alere Inc. (US)
  • Beckman Coulter, Inc. (US)
  • Chek Diagnostics (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Home Access Health Corporation (US)
  • Siemens Healthcare (Germany)

11. GLOBAL MARKET PERSPECTIVE

    • Table 24: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for Cholesterol Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 26: World 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
  • Market by Test Type
    • Table 27: World Recent Past, Current & Future Analysis for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for Lipid Panel/ Complete Lipid Profile Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 29: World 15-Year Perspective for Lipid Panel/Complete Lipid Profile Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for Apolipoprotein B Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Apolipoprotein B Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 32: World 15-Year Perspective for Apolipoprotein B Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 33: World Recent Past, Current & Future Analysis for Other Cholesterol Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for Other Cholesterol Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Tests in Millions for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 35: World 15-Year Perspective for Other Cholesterol Tests by Geographic Region - Percentage Breakdown of Tests for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Surge in CVD Incidence - Major Growth Factor
    • Table 36: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart)
    • Table 37: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)
    • Table 38: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)
    • Ageing Population - Vital Demography
    • Table 39: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • The Risk of CVD in Chronic Conditions to Drive Testing Market
      • Opportunity Indicators
    • Table 40: Obesity Prevalence in US Adults by Type of Obesity (2013) (includes corresponding Graph/Chart)
    • Table 41: Obesity Prevalence in the US by Age Group (2013) (includes corresponding Graph/Chart)
    • Table 42: Obesity Prevalence in the US by Percentage Annual Income Level (2013) (includes corresponding Graph/Chart)
    • Table 43: US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart)
    • Table 44: Diabetes Prevalence in the US by Type (2013) (includes corresponding Graph/Chart)
    • Table 45: High Blood Pressure Prevalence in the US (2012): Prevalence Rates for Male and Female Population by Age Groups (includes corresponding Graph/Chart)
    • Table 46: High Blood Pressure Prevalence in the US (2012): Prevalence Rates for Male and Female Population by Ethnic Group (includes corresponding Graph/Chart)
    • Increasing Cardiovascular Ailments Drive Sales of Home Test Devices
    • Cholesterol POCT Market: An Overview
      • Cholesterol Testing - NCEP Recommendations Spurs Potential
    • Innovations Drive the Usage of Cardiovascular Monitoring Systems
    • Sterols and Stanols: Cholesterol-Lowering Products
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 47: US Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 48: US Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 49: US 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Product Launch
  • B. Market Analytics
    • Table 50: Canadian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 51: Canadian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 52: Canadian 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 53: Japanese Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Japanese Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 55: Japanese 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Product Launch
  • B. Market Analytics
    • Table 56: European Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 57: European Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 58: European 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 59: European Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 60: European Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 61: European 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 62: French Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 63: French Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 64: French 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Siemens Healthcare - Key German Player
  • B. Market Analytics
    • Table 65: German Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 66: German Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 67: German 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 68: Italian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 69: Italian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 70: Italian 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analysis
    • Table 71: UK Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 72: UK Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 73: UK 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 74: Spanish Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 75: Spanish Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 76: Spanish 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 77: Russian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 78: Russian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 79: Russian 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/ Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Product Launch
    • F. Hoffmann-La Roche Ltd. - A Key Swiss Player
  • B. Market Analytics
    • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Rest of Europe Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 82: Rest of Europe 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • The Largest Market Worldwide
  • B. Market Analytics
    • Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 85: Asia-Pacific 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for China, India, and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Asia-Pacific Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 88: Asia-Pacific 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Corporate Development
  • B. Market Analytics
    • Table 89: Chinese Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Chinese Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 91: Chinese 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • Corporate Development
  • B. Market Analytics
    • Table 92: Indian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Indian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 94: Indian 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Corporate Development
  • B. Market Analytics
    • Table 95: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 96: Rest of Asia-Pacific Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 97: Rest of Asia-Pacific 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 98: Latin American Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 99: Latin American Historic Review for Cholesterol Testing by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 100: Latin American 15-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Tests for Brazil, and Rest of Latin America Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 101: Latin American Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 102: Latin American Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 103: Latin American 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 104: Brazilian Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 105: Brazilian Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 106: Brazilian 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 107: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 108: Rest of Latin America Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 109: Rest of Latin America 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 110: Rest of World Recent Past, Current & Future Analysis for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 111: Rest of World Historic Review for Cholesterol Testing by Test Type - Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests Independently Analyzed with Annual Tests in Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 112: Rest of World 15-Year Perspective for Cholesterol Testing by Test Type - Percentage Breakdown of Tests for Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Cholesterol Tests for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top